Document › Details
Brainshake Ltd.. (9/14/16). "Press Release: Brainshake Closes €3.5m to Advance Regulatory Approval of Blood Analysis Service". Helsinki.
|Organisation||Brainshake Ltd. (FI)|
|Organisation 2||Cor Group (FI)|
|Product 2||metabolomic services|
|Index term||Brainshake–SEVERAL: investment, 201607 financing round Series A €3.5m led by Cor Group + incl Tekes + Nordea + Finnvera|
Finnish Brainshake has raised 3.5 million euros in Series A funding. The investment will be used to advance regulatory approval and internationalization of its blood analysis service.
Brainshake’s blood analysis service provides more than 220 biomarkers from a single blood sample – 50 times more than commonly used laboratory methods. Biomarkers reflect the health state of an individual and can be used to predict disease risk in chronic diseases. Brainshake’s blood analysis, backed up by 100 peer-reviewed scientific publications, is used by leading universities globally.
“Our technology has been proven by peer-reviewed science and the epidemiological studies show the power of our data in risk assessment of chronic diseases. Now we are bringing the technology to routine healthcare with the ultimate target to enable prevention of the world’s number one health problem”, says Teemu Suna , CEO, Brainshake.
The 3.5 million investment is led by Cor Group, a Finnish growth venture, joining Brainshake as a shareholder and long-term strategic partner. Other parties of the financial package include Tekes, Nordea and Finnvera. Brainshake is also a member of one of the world’s biggest health-focused start-up accelerators StartUp Health.
“We have worked in the global healthcare market for nearly 30 years, and consider Brainshake’s blood analysis highly impressive. We look forward to working together to create a global market leader and to advance the company’s mission to transform preventive medicine in chronic diseases together with our Group. Our goal is to work with Brainshake as a long-term strategic partner, an active member of the board and co-owner”, says Olli Karhi , board member, Cor Group.
Helsinki-based Brainshake has 15 employees in Finland. In 2015, the company’s turnover was 1,6 million euros.
Teemu Suna, CEO, Brainshake, tel. +358 40 196 1669, email@example.com
Brainshake Ltd. is a blood analysis company redesigning global healthcare through the power of metabolic profiling. With technology backed up by 100 peer-reviewed biomedical publications, Brainshake provides disruptive blood analysis service to advance precision medicine in chronic diseases. For more information please visit www.brainshake.fi .
Teknobulevardi 3-5 01530 Vantaa, FINLAND
+358 40 755 2468
Record changed: 2016-10-10
More documents for Brainshake Ltd. (FI)
-  Brainshake Ltd.. (10/3/16). "Press Release: Blood Analysis Company Brainshake Closes Funding of €2M Three Months after First Round". Helsinki & Santa Clara, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]